MPND
gene geneOn this page
Also known as FLJ14981
Summary
MPND (MPN domain containing, HGNC:25934) is a protein-coding gene on chromosome 19p13.3, encoding MPN domain-containing protein (Q8N594). Probable protease.
Predicted to enable metallopeptidase activity and polyubiquitin modification-dependent protein binding activity. Predicted to be involved in double-strand break repair. Predicted to be part of BRCA1-A complex and BRISC complex.
Source: NCBI Gene 84954 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 112 total
- MANE Select transcript:
NM_001300862
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25934 |
| Approved symbol | MPND |
| Name | MPN domain containing |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14981 |
| Ensembl gene | ENSG00000008382 |
| Ensembl biotype | protein_coding |
| Entrez | 84954 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 2 nonsense_mediated_decay
ENST00000262966, ENST00000359935, ENST00000594162, ENST00000594716, ENST00000596722, ENST00000597036, ENST00000599840, ENST00000601877, ENST00000927551, ENST00000964906, ENST00000964907, ENST00000964908, ENST00000964909, ENST00000964910
RefSeq mRNA: 3 — MANE Select: NM_001300862
NM_001159846, NM_001300862, NM_032868
CCDS: CCDS42470, CCDS54200, CCDS74261
Canonical transcript exons
ENST00000599840 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000361069 | 4354045 | 4354129 |
| ENSE00000664087 | 4345745 | 4345981 |
| ENSE00000664090 | 4352897 | 4353029 |
| ENSE00000664094 | 4355097 | 4355173 |
| ENSE00000664098 | 4358083 | 4358172 |
| ENSE00000868749 | 4359163 | 4359255 |
| ENSE00000868751 | 4357515 | 4357585 |
| ENSE00000868752 | 4357253 | 4357421 |
| ENSE00000868753 | 4354949 | 4355021 |
| ENSE00000868754 | 4354324 | 4354420 |
| ENSE00001208144 | 4343708 | 4343994 |
| ENSE00003057225 | 4359916 | 4360078 |
| ENSE00003173924 | 4343562 | 4343600 |
Expression profiles
Bgee: expression breadth ubiquitous, 196 present calls, max score 93.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0935 / max 163.1378, expressed in 1761 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173336 | 4.6226 | 1682 |
| 173337 | 2.1938 | 807 |
| 173335 | 1.2771 | 495 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 93.68 | gold quality |
| ileal mucosa | UBERON:0000331 | 92.47 | gold quality |
| right lobe of liver | UBERON:0001114 | 90.89 | gold quality |
| apex of heart | UBERON:0002098 | 90.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 89.51 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 88.36 | gold quality |
| transverse colon | UBERON:0001157 | 87.89 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 87.36 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.33 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.05 | gold quality |
| cortical plate | UBERON:0005343 | 86.73 | gold quality |
| granulocyte | CL:0000094 | 86.49 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.35 | gold quality |
| monocyte | CL:0000576 | 86.26 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.20 | gold quality |
| leukocyte | CL:0000738 | 86.12 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.05 | gold quality |
| amygdala | UBERON:0001876 | 85.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.90 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.60 | gold quality |
| body of stomach | UBERON:0001161 | 85.53 | gold quality |
| duodenum | UBERON:0002114 | 85.44 | gold quality |
| neocortex | UBERON:0001950 | 85.40 | gold quality |
| liver | UBERON:0002107 | 85.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.27 | gold quality |
| sural nerve | UBERON:0015488 | 85.09 | gold quality |
| frontal cortex | UBERON:0001870 | 84.97 | gold quality |
| colon | UBERON:0001155 | 84.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.60 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mpnd | ENSDARG00000061989 |
| mus_musculus | Mpnd | ENSMUSG00000003199 |
| rattus_norvegicus | Mpnd | ENSRNOG00000048282 |
Paralogs (3): SMARCC2 (ENSG00000139613), MYSM1 (ENSG00000162601), SMARCC1 (ENSG00000173473)
Protein
Protein identifiers
MPN domain-containing protein — Q8N594 (reviewed: Q8N594)
All UniProt accessions (7): Q8N594, M0QXC4, M0QXK5, M0R044, M0R0F2, M0R189, W4VSR2
UniProt curated annotations — full annotation on UniProt →
Function. Probable protease. Acts as a sensor of N(6)-methyladenosine methylation on DNA (m6A): recognizes and binds m6A DNA, leading to its degradation. Binds only double strand DNA (dsDNA) in a sequence-independent manner.
Subunit / interactions. Monomer. Mainly monomoric, but when binds to dsDNA, forms homotetramer assembled into two homodimers. May interact with histones; this interaction is facilitated by dsDNA binding.
Post-translational modifications. Degraded following binding to N(6)-methyladenosine methylated DNA (m6A).
Domain organisation. The RAMA domain recognizes and binds N(6)-methyladenosine methylation on DNA (m6A). The RAMA domain mediates interaction with histones. The two acidic regions inhibit DNA binding. The two acidic regions promotes histone interaction.
Similarity. Belongs to the peptidase M67 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N594-1 | 1 | yes |
| Q8N594-2 | 2 |
RefSeq proteins (3): NP_001153318, NP_001287791, NP_116257 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000555 | JAMM/MPN+_dom | Domain |
| IPR037518 | MPN | Domain |
| IPR040843 | RAMA | Domain |
| IPR050242 | JAMM_MPN+_peptidase_M67A | Family |
Pfam: PF01398, PF18755
UniProt features (24 total): binding site 6, compositionally biased region 4, modified residue 4, domain 2, splice variant 2, region of interest 2, initiator methionine 1, chain 1, sequence conflict 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N594-F1 | 72.14 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (6): 123; 125; 145; 349; 351; 362
Post-translational modifications (4): 2, 8, 178, 181
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 114 (showing top):
GOMF_METALLOPEPTIDASE_ACTIVITY, BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_DNA_DAMAGE_RESPONSE, GOBP_PROTEOLYSIS, chr19p13, GOBP_DNA_METABOLIC_PROCESS, GOMF_PEPTIDASE_ACTIVITY, GOBP_DNA_REPAIR, GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY, CHEN_METABOLIC_SYNDROM_NETWORK, GOCC_BRCA1_A_COMPLEX, GOCC_BRISC_COMPLEX, GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING, GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING
GO Biological Process (2): double-strand break repair (GO:0006302), proteolysis (GO:0006508)
GO Molecular Function (7): metallopeptidase activity (GO:0008237), polyubiquitin modification-dependent protein binding (GO:0031593), metal ion binding (GO:0046872), metal-dependent deubiquitinase activity (GO:0140492), protein binding (GO:0005515), peptidase activity (GO:0008233), hydrolase activity (GO:0016787)
GO Cellular Component (2): BRCA1-A complex (GO:0070531), BRISC complex (GO:0070552)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nuclear protein-containing complex | 2 |
| DNA repair | 1 |
| protein metabolic process | 1 |
| peptidase activity | 1 |
| modification-dependent protein binding | 1 |
| cation binding | 1 |
| metallopeptidase activity | 1 |
| deubiquitinase activity | 1 |
| binding | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
2238 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MPND | COPS6 | Q7L5N1 | 680 |
| MPND | JOSD2 | Q8TAC2 | 647 |
| MPND | COPS5 | Q92905 | 645 |
| MPND | JOSD1 | Q15040 | 638 |
| MPND | STAMBPL1 | Q96FJ0 | 612 |
| MPND | ATXN3L | Q9H3M9 | 578 |
| MPND | EIF3C | Q99613 | 569 |
| MPND | EIF3F | O00303 | 557 |
| MPND | ATXN3 | P54252 | 555 |
| MPND | ZUP1 | Q96AP4 | 540 |
| MPND | STAMBP | O95630 | 521 |
| MPND | MINDY1 | Q8N5J2 | 513 |
| MPND | PSMD14 | O00487 | 507 |
| MPND | EIF3H | O15372 | 472 |
| MPND | PSMD7 | P51665 | 471 |
IntAct
73 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| QPRT | PIK3C2A | psi-mi:“MI:0914”(association) | 0.640 |
| DCTN1 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| DMWD | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | psi-mi:“MI:0915”(physical association) | 0.560 | |
| HOXD10 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NF2 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOS3 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKN | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | PRPS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KIF1B | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF11 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | HTRA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | JPH3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MPND | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SOD1 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| APP | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNCA | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATXN1 | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
| TARDBP | MPND | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (19): MPND (PCA), MPND (Affinity Capture-Western), MPND (Proximity Label-MS), MPND (Proximity Label-MS), MPND (Proximity Label-MS), MPND (Proximity Label-MS), MPND (Two-hybrid), MPND (Affinity Capture-MS), MPND (Affinity Capture-MS), MPND (Affinity Capture-MS), MPND (Affinity Capture-MS), SNAI1 (Affinity Capture-Western), MPND (Proximity Label-MS), MPND (Affinity Capture-MS), MPND (Affinity Capture-MS)
ESM2 similar proteins: A3KP59, A5PK74, A6QQJ8, D3YY23, D3ZU57, E2RDP2, O75064, O95382, O95398, P0C5W1, P0C7A1, P16386, P52824, P54310, Q0P5G1, Q15477, Q1JPD6, Q1L5Z9, Q3T1I9, Q3TV65, Q3U1Y4, Q562E7, Q5ZMM1, Q684M2, Q68J42, Q6NZR5, Q766D5, Q76MJ5, Q80TE0, Q86TL0, Q8BGV9, Q8BIW9, Q8BMZ5, Q8BX80, Q8C052, Q8IV53, Q8K1S6, Q8N594, Q8NFI3, Q8R5G7
Diamond homologs: A0A8M3B525, A5PJP6, B0KWU8, B2RYM5, B5X8M4, E2AXC7, O35864, P46736, P46737, Q3TV65, Q4VA72, Q5R9L6, Q66GV6, Q6GLM9, Q6P635, Q6PC30, Q7M757, Q8H936, Q8N594, Q92905, Q9LT08, A6ZXB7, B3LH96, O94454, P91001, Q12468, Q4IJM4, Q4P804, Q6BMQ3, Q6C703, Q7RXX8, Q9FVU9, Q8LAZ7, Q54PF3, A0JMR6, B6MUN4, D4GTS4, P97496, Q08CH3, Q54Z40
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 25 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| adult locomotory behavior | 5 | 62.7× | 6e-06 |
| learning | 5 | 58.5× | 6e-06 |
| negative regulation of neuron apoptotic process | 5 | 23.1× | 2e-04 |
| positive regulation of apoptotic process | 5 | 11.8× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
112 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 99 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2043 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:4345739:CTGCA:C | acceptor_loss | 1.0000 |
| 19:4345740:TGCA:T | acceptor_loss | 1.0000 |
| 19:4345741:GCAGG:G | acceptor_loss | 1.0000 |
| 19:4345743:A:AG | acceptor_gain | 1.0000 |
| 19:4345743:A:AT | acceptor_loss | 1.0000 |
| 19:4345743:AG:A | acceptor_gain | 1.0000 |
| 19:4345743:AGG:A | acceptor_gain | 1.0000 |
| 19:4345744:G:GG | acceptor_gain | 1.0000 |
| 19:4345744:GG:G | acceptor_gain | 1.0000 |
| 19:4345744:GGG:G | acceptor_gain | 1.0000 |
| 19:4345982:GTAC:G | donor_loss | 1.0000 |
| 19:4345983:T:A | donor_loss | 1.0000 |
| 19:4352896:GA:G | acceptor_gain | 1.0000 |
| 19:4353001:G:GT | donor_gain | 1.0000 |
| 19:4354041:CCA:C | acceptor_loss | 1.0000 |
| 19:4354042:CA:C | acceptor_loss | 1.0000 |
| 19:4354043:A:AG | acceptor_gain | 1.0000 |
| 19:4354043:A:AT | acceptor_loss | 1.0000 |
| 19:4354043:AGAG:A | acceptor_gain | 1.0000 |
| 19:4354044:G:GT | acceptor_gain | 1.0000 |
| 19:4354044:GA:G | acceptor_gain | 1.0000 |
| 19:4354044:GAGG:G | acceptor_gain | 1.0000 |
| 19:4354044:GAGGC:G | acceptor_gain | 1.0000 |
| 19:4354126:CCAG:C | donor_loss | 1.0000 |
| 19:4354127:CAGG:C | donor_loss | 1.0000 |
| 19:4354129:GGTCA:G | donor_loss | 1.0000 |
| 19:4354130:G:GA | donor_loss | 1.0000 |
| 19:4354321:CAGGA:C | acceptor_loss | 1.0000 |
| 19:4354322:AGGAA:A | acceptor_loss | 1.0000 |
| 19:4355020:GA:G | donor_gain | 1.0000 |
AlphaMissense
3261 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:4345754:T:C | F102L | 1.000 |
| 19:4345755:T:C | F102S | 1.000 |
| 19:4345756:C:A | F102L | 1.000 |
| 19:4345756:C:G | F102L | 1.000 |
| 19:4345785:T:A | I112N | 1.000 |
| 19:4345785:T:C | I112T | 1.000 |
| 19:4345811:T:C | F121L | 1.000 |
| 19:4345813:C:A | F121L | 1.000 |
| 19:4345813:C:G | F121L | 1.000 |
| 19:4345821:C:A | P124H | 1.000 |
| 19:4345829:T:A | W127R | 1.000 |
| 19:4345829:T:C | W127R | 1.000 |
| 19:4345830:G:C | W127S | 1.000 |
| 19:4345831:G:C | W127C | 1.000 |
| 19:4345831:G:T | W127C | 1.000 |
| 19:4345833:C:A | A128D | 1.000 |
| 19:4345842:G:A | C131Y | 1.000 |
| 19:4345843:C:G | C131W | 1.000 |
| 19:4345844:A:G | K132E | 1.000 |
| 19:4345846:G:C | K132N | 1.000 |
| 19:4345846:G:T | K132N | 1.000 |
| 19:4345881:G:A | G144D | 1.000 |
| 19:4345883:T:A | W145R | 1.000 |
| 19:4345883:T:C | W145R | 1.000 |
| 19:4345885:G:C | W145C | 1.000 |
| 19:4345885:G:T | W145C | 1.000 |
| 19:4345893:T:A | V148D | 1.000 |
| 19:4345927:G:C | K159N | 1.000 |
| 19:4345927:G:T | K159N | 1.000 |
| 19:4343978:T:C | L93P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000016607 (19:4347490 C>T), RS1000088517 (19:4347328 C>T), RS1000299437 (19:4342271 G>C), RS1000474617 (19:4347639 G>A), RS1000849681 (19:4355885 C>T), RS1001069301 (19:4357176 T>C,G), RS1001087623 (19:4355590 C>T), RS1001200536 (19:4357114 G>A,T), RS1001430594 (19:4360200 C>G,T), RS1001436868 (19:4356911 A>C,G), RS1001558586 (19:4359327 C>A), RS1001742340 (19:4348519 A>C,G,T), RS1001794186 (19:4359492 G>A), RS1001905463 (19:4344093 G>A), RS1001944905 (19:4344250 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010042_36 | Asthma | 2.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression | 2 |
| Aflatoxin B1 | affects expression, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sulforaphane | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Genistein | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1XF | Abcam HeLa MPND KO | Cancer cell line | Female |
| CVCL_SY83 | HAP1 MPND (-) 1 | Cancer cell line | Male |
| CVCL_SY84 | HAP1 MPND (-) 2 | Cancer cell line | Male |
| CVCL_XQ60 | HAP1 MPND (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.